The Georgian Health Digest: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on The Georgian Health Digest.

January 2026

Mo	Tu	We	Th	Fr	Sa	Su
			1	2	3	4
5	6	7	8	9	10	11
12	13	14	15	16	17	18
19	20	21	22	23	24	25
26	27	28	29	30	31

February 2026

Mo	Tu	We	Th	Fr	Sa	Su
						1
2	3	4	5	6	7	8
9	10	11	12	13	14	15
16	17	18	19	20	21	22
23	24	25	26	27	28

March 2026

Mo	Tu	We	Th	Fr	Sa	Su
						1
2	3	4	5	6	7	8
9	10	11	12	13	14	15
16	17	18	19	20	21	22
23	24	25	26	27	28	29
30	31

Press releases published on February 24, 2026

Feb. 24, 2026

Smith+Nephew signs exclusive US distribution agreement with RMR Ortho for patented technology that provides a unique dynamic compression nitinol fixation option (A'TOMIC™) to our surgeons

GlobeNewswire

Feb. 24, 2026

Centre for Neuro Skills Physician-Researcher Dr. Brent Masel to Receive NABIS Legends Award for Lifetime of Contributions to Traumatic Brain Injury Care

GlobeNewswire

Feb. 24, 2026

Early Registration Deadline Approaching: Secure Your Spot at ACMA 2026 in Orlando

GlobeNewswire

Feb. 24, 2026

Siren Biotechnology Receives FDA Fast Track Designation for SRN-101 for the Treatment of Recurrent High-Grade Glioma

GlobeNewswire

Feb. 24, 2026

Respiree Strengthens Series A Syndicate to Advance Next-Generation Cardiorespiratory Care

GlobeNewswire

Feb. 24, 2026

RxLogic Affirms Commitment to Compliance and Transparency as PBM Regulatory Expectations Expand

GlobeNewswire

Feb. 24, 2026

A4M Claims Institutional Ownership of Longevity Medicine, Launches Longevity SpringFest

GlobeNewswire

Feb. 24, 2026

Communiqué de presse : Dupixent de Sanofi et Regeneron est approuvé aux États-Unis comme le premier et le seul médicament pour la rhinosinusite fongique allergique

GlobeNewswire

Feb. 24, 2026

Press Release: Sanofi and Regeneron’s Dupixent approved in the US as the first and only medicine for allergic fungal rhinosinusitis

GlobeNewswire

Feb. 24, 2026

Global Protein Microarrays Market to Reach USD 1.78 Billion by 2030 | MarketsandMarkets™

GlobeNewswire

Feb. 24, 2026

Dupixent® (dupilumab) Approved in the U.S. as the First and Only Medicine for Allergic Fungal Rhinosinusitis (AFRS)

GlobeNewswire

Feb. 24, 2026

DIAGNOS to present at Centurion One Capital 9th Annual Toronto Growth Conference

GlobeNewswire

Feb. 24, 2026

DIAGNOS présentera à la 9e conférence annuelle sur la croissance de Centurion One Capital à Toronto

GlobeNewswire

Feb. 24, 2026

Professional Golfer Max Homa Joins Arcutis’ Free to Be Me Campaign, Urging Individuals with Seborrheic Dermatitis to Tee Up a Conversation with Their Healthcare Provider About Long-Term Treatments

GlobeNewswire

Feb. 24, 2026

Senti Biosciences to Present at TD Cowen 46th Annual Health Care Conference

GlobeNewswire

Feb. 24, 2026

Edesa Biotech Reports Additional Positive Results from Phase 3 Paridiprubart Study

GlobeNewswire

Feb. 24, 2026

PacBio and DNAstack Launch First Global Federated HiFi Whole Genome Dataset to Accelerate Rare Disease Research

GlobeNewswire

Feb. 24, 2026

Dentsply Sirona and Burkhart Dental Supply Announce Expanded Distribution Partnership to Include Dental Technology Equipment

GlobeNewswire

Feb. 24, 2026

Six presented abstracts at ASCO-GU 2026 reinforce the clinical impact of Myriad’s Precise MRD, Prolaris, and MyRisk tests

GlobeNewswire

Feb. 24, 2026

Resmed Expands U.S. Operations with New Distribution Center in Greenwood, Indiana

GlobeNewswire